PortfoliosLab logo

Acurx Pharmaceuticals, Inc. (ACXP)

Equity · Currency in USD · Last updated Aug 11, 2022

Company Info

ISINUS00510M1045
CUSIP00510M104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.78
Year Range$2.42 - $5.80
EMA (50)$3.68
EMA (200)$3.99
Average Volume$22.11K
Market Capitalization$49.06M

ACXPShare Price Chart


Chart placeholderClick Calculate to get results

ACXPPerformance

The chart shows the growth of $10,000 invested in Acurx Pharmaceuticals, Inc. in Jun 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $7,967 for a total return of roughly -20.33%. All prices are adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%MarchAprilMayJuneJulyAugust
21.02%
-4.35%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M27.47%7.97%
6M18.02%-6.88%
YTD10.62%-11.66%
1Y-0.62%-5.01%
5Y-18.27%-1.17%
10Y-18.27%-1.17%

ACXPMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-3.73%-12.52%-9.87%13.72%-27.88%40.89%-5.54%33.52%
20216.33%-10.97%-8.98%-0.58%-2.72%-4.00%-9.98%

ACXPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acurx Pharmaceuticals, Inc. Sharpe ratio is -0.04. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.70-0.60-0.50-0.40-0.30-0.20-0.100.00Jul 03Jul 10Jul 17Jul 24Jul 31Aug 07
-0.04
-0.25
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPDividend History


Acurx Pharmaceuticals, Inc. doesn't pay dividends

ACXPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-39.42%
-12.22%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPWorst Drawdowns

The table below shows the maximum drawdowns of the Acurx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acurx Pharmaceuticals, Inc. is 69.33%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-69.33%Jun 28, 2021230May 24, 2022

ACXPVolatility Chart

Current Acurx Pharmaceuticals, Inc. volatility is 47.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%MarchAprilMayJuneJulyAugust
47.83%
16.23%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)